M MRK

Merck & Co Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Merck & Company Inc. (MRK) is a prominent global healthcare leader headquartered in Kenilworth, New Jersey, recognized for its innovative contributions to pharmaceuticals and vaccines aimed at improving health outcomes worldwide. Established in 1891, Merck boasts a diverse product portfolio that add...

$149.52

+2.18% (+$3.19)

Volume 12.35M

52W High $156.92

52W Low $82.01

Market Cap $364.38B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 29, 2026 Beat

Actual: $2.49 vs. Consensus: $2.12

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q3 2026 Oct 29, 2026

1-Day: +2.18%

Q2 2026 Aug 4, 2026

1-Day: +0.26%

Q1 2026 Apr 30, 2026

1-Day: +2.73%

5-Day: +3.64%

Q1 2026 Apr 23, 2026

1-Day: -2.95%

5-Day: -4.57%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$18.09B	+5.3%	81.4%	40.6%	$5.07B
Q2'26	$16.61B	+5.1%	73.5%	-4.1%	-$1.34B
Q1'26	$16.29B	+4.3%	81.9%	-11.6%	-$4.24B
Q4'25	$16.32B	+4.5%	70.5%	37.7%	$2.96B
Q3'25	$17.18B	+3.2%	75.6%	43.4%	$5.79B
Q2'25	$15.80B	-1.9%	75.7%	40.3%	$4.43B
Q1'25	$15.62B	-1.0%	75.1%	43.0%	$5.08B
Q4'24	$15.62B	+6.8%	75.5%	27.8%	$3.74B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 29, 2026	$2.12	$2.30	$2.49	+17.45%	Beat
Q2 2026	Aug 4, 2026	-$0.26	-$0.26	-$0.13	+50.00%	Beat
Q1 2026	Apr 30, 2026	-$1.47	-$1.50	-$1.28	+12.93%	Beat
Q1 2026	Apr 23, 2026	-$0.41	-$0.41	--	--	--
Q4 2025	Feb 3, 2026	$2.01	$2.07	$2.04	+1.49%	Missed
Q3 2025	Oct 30, 2025	$2.35	$2.48	$2.58	+9.79%	Beat
Q2 2025	Jul 29, 2025	$2.03	$2.10	$2.13	+4.93%	Beat
Q1 2025	Apr 24, 2025	$2.14	$2.25	$2.22	+3.74%	Missed
Q4 2024	Feb 4, 2025	$1.67	$1.92	$1.72	+2.99%	Missed
Q3 2024	Oct 31, 2024	$1.57	$1.81	$1.57	+0.00%	Missed
Q2 2024	Jul 30, 2024	$2.14	$2.47	$2.28	+6.54%	Missed
Q1 2024	Apr 25, 2024	$1.92	$2.16	$2.07	+7.81%	Missed